Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients
- Authors
- Lim, Sun Min; Hong, Min Hee; Ha, Sang-Jun; Hwang, Daehee; Chae, Sehyun; Koh, Yoon Woo; Choi, Eun Chang; Kim, Se-Heon; Kim, Da-Hee; Yoon, Sun Och; Kim, Hye Ryun
- Issue Date
- Sep-2021
- Publisher
- SPRINGER
- Keywords
- Squamous cell carcinoma of head and neck; Biomarkers; Programmed death-ligand; Poliovirus receptor
- Citation
- JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, v.147, no.9, pp.2741 - 2750
- Journal Title
- JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Volume
- 147
- Number
- 9
- Start Page
- 2741
- End Page
- 2750
- URI
- http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/300
- DOI
- 10.1007/s00432-021-03531-8
- ISSN
- 0171-5216
- Abstract
- Purpose We aimed to investigate the prognostic value of multiple immune cell markers including programmed death-ligand 1 (PD-L1) and poliovirus receptor (PVR) in head and neck squamous cell carcinoma (HNSCC) using archival tumor tissues Methods Patients diagnosed with HNSCC who have undergone surgical resection in 2005-2012 were included. Correlations between PVR and PD-L1 expression and patient characteristics were analyzed by analysis of variance. The Kaplan-Meier method and log-rank test were used to estimate survival. P values < 0.05 were considered statistically significant. Results In total, 375 primary tumor tissues were analyzed using immunohistochemistry. High PVR expression was associated with a poor prognosis in terms of overall survival (OS) and recurrence-free survival (RFS), and tumors with high PVR expression were associated with a short OS. PD-L1 tumor expression did not have a prognostic impact on survival. Univariate analysis revealed that OS and RFS were affected by age and p16 and PVR expression; multivariate analysis revealed that age and p16 and PVR expression were the most important determinants of RFS. Conclusion PVR overexpression is a poor prognostic factor in patients with HNSCC and co-targeting PVR and PD-L1 may be a promising therapeutic option that needs further investigation.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 연구본부 > 신경·혈관 단위체 연구그룹 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.